Susan Evans‐Axelsson
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Oncology
- Molecular Biology
- Cancer Research
- Co-authors
- Anders BjartellRebecka HellstenGiacomo CanesinAgnieszka KrzyzanowskaTommy AnderssonRoger SlavikAndreea D. StuparuJohannes Czernin
- Topics
- Prostate Cancer Treatment and Research (13 papers)Radiopharmaceutical Chemistry and Applications (8 papers)Prostate Cancer Diagnosis and Treatment (3 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Susan Evans‐Axelsson
18 papers receiving 437 citations
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 226
- Radiology, Nuclear Medicine and Imaging 179
- Oncology 162
- Molecular Biology 137
- Cancer Research 58
Countries citing papers authored by Susan Evans‐Axelsson
This map shows the geographic impact of Susan Evans‐Axelsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Evans‐Axelsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Evans‐Axelsson more than expected).
Fields of papers citing papers by Susan Evans‐Axelsson
This network shows the impact of papers produced by Susan Evans‐Axelsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Evans‐Axelsson. The network helps show where Susan Evans‐Axelsson may publish in the future.
Co-authorship network of co-authors of Susan Evans‐Axelsson
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Evans‐Axelsson. A scholar is included among the top collaborators of Susan Evans‐Axelsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Evans‐Axelsson. Susan Evans‐Axelsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 24 | |
| 6 | 19 | |
| 7 | 36 | |
| 8 | 24 | |
| 9 | 64 | |
| 10 | 36 | |
| 11 | 64 | |
| 12 | 28 | |
| 13 | 23 | |
| 14 | 40 | |
| 15 | 8 | |
| 16 | 20 | |
| 17 | Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer. | 1 |
| 18 | 11 | |
| 19 | 24 | |
| 20 | The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models. | 15 |
About Susan Evans‐Axelsson
Susan Evans‐Axelsson is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 21 papers that have together received 439 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (179 citations), Pulmonary and Respiratory Medicine (226 citations) and Oncology (162 citations). Susan Evans‐Axelsson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Anders Bjartell, Rebecka Hellsten, Giacomo Canesin, Agnieszka Krzyzanowska, Tommy Andersson, Roger Slavik, Andreea D. Stuparu, Johannes Czernin, Caius G. Radu and Katharina Lückerath. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.